SCHEMBL1144796

SCHEMBL1144796

COC(=O)c1cc(OC)c2oc(C)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 2/20 0.44
TSHR P16473 1/20 0.43
CNR2 P34972 1/20 0.43
MAPT P10636 3/20 0.41
ATM Q13315 2/20 0.41
POLB P06746 3/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
RAB9A P51151 2/20 0.39
NFKB1 P19838 2/20 0.39
NFKB2 Q00653 2/20 0.39
RELA Q04206 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144545 0.87 CA12 (0.49) ALDH1A1TSHRCNR2POLBESR1
SCHEMBL17686403 0.84 ALDH1A1 (0.45) KDM4EALDH1A1CYP3A4TSHRCNR2
SCHEMBL643327 0.84 KDM4E (0.50) KDM4EALDH1A1CNR2MAPTATM
SCHEMBL31239486 0.82 KDM4E (0.42) KDM4EALDH1A1MAPTATMPOLB
SCHEMBL20844762 0.82 KDM4E (0.42) KDM4EALDH1A1MAPTATMPOLB
SCHEMBL22300744 0.80 LMNA (0.52) KDM4ECYP3A4TSHRMAPTKMT2A
SCHEMBL24818517 0.79 NOTUM (0.43) KDM4EALDH1A1MAPTATMRAB9A
SCHEMBL11391272 0.76 KDM4E (0.48) KDM4EALDH1A1CYP3A4MAPTATM
SCHEMBL23772190 0.75 CYP3A4 (0.44) KDM4EALDH1A1CYP3A4TSHRMAPT
SCHEMBL21729783 0.74 KDM4E (0.55) KDM4EALDH1A1CYP3A4TSHRCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297163-B1 Pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER (US) 2015-07-08 EP disclosed
US-8318762-B2 Pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2012-11-27 US disclosed
EP-2297163-A1 PYRAZOLOSPIROKETONE ACETYL-C0A CARBOXYLASE INHIBITORS Pfizer Inc. (US) 2011-03-23 EP disclosed
US-20110028390-A1 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors PFIZER, INC. (US) 2011-02-03 US disclosed
WO-2009144554-A1 PYRAZOLOSPIROKETONE ACETYL-C0A CARBOXYLASE INHIBITORS PFIZER, INC. (US) 2009-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028390-A1 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors ACACA, PC, ACACB KDM4E 1055/4885ALDH1A1 164/4885CYP3A4 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.